Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial update evaluating an oncolytic adenovirus in combination with a PD-1 inhibitor for non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-09-30Clinical Trial Update: Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer [Phase 2]
Phase 2 trial updating pembrolizumab as maintenance therapy after initial chemotherapy in metastatic bladder cancer; study completed with re…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma [Phase 4]
Phase 4 clinical study evaluating disitamab vedotin with penpulimab as neoadjuvant therapy for HER2-expressing cisplatin-intolerant bladder …
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2b study of UGN-102 for low-grade, intermediate-risk non-muscle-invasive bladder cancer has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery [Phase 3]
Phase 3 clinical trial update exploring multicenter preventive antibiotics with cystectomy within enhanced recovery after surgery for bladde…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 trial evaluating CV301 in combination with PD-1/PD-L1 blockade in locally advanced or metastatic bladder cancer has completed with p…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of radiation therapy and chemotherapy for Stage I bladder cancer. Conducted by the Radiati…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Clinical trial update for avelumab plus BCG in non-muscle invasive bladder cancer (Phase 1/2) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors [Phase 2]
Phase 2 trial exploring DPX-Survivac with low-dose cyclophosphamide and pembrolizumab in selected advanced solid tumors; currently active/no…
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy [Phase 2]
Phase 2 trial investigating nivolumab with chemoradiotherapy for muscle-invasive bladder cancer in patients not undergoing cystectomy.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer [Phase 2]
Phase 2 trial evaluating durvalumab for non-muscle-invasive bladder cancer is underway; full results are not yet available.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer [Phase 2]
Phase II study evaluating TAS-102 (Lonsurf) in metastatic bladder cancer resistant to platinum therapy and checkpoint inhibitors.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating eribulin mesylate in combination with gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) [Phase 3]
Phase 3 trial evaluating immediate postoperative intravesical instillation with either gemcitabine or epirubicin for bladder cancer; current…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cytokine-induced killer cells for metastatic urogenital tumors (bladder and renal cancer) is ongoing b…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial of nab-paclitaxel plus gemcitabine as first-line therapy for cisplatin-ineligible or cisplatin-incurable advanced urothelial c…
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer [Phase 2]
Phase 2 SWOG S1314 COXEN program completed to predict chemotherapy response in bladder cancer; results were posted in January 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of enfortumab vedotin in locally advanced or metastatic urothelial cancer has been completed and results have been posted. The…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer [Phase 3]
Phase 3 trial evaluating adjuvant nivolumab vs placebo after surgical resection for bladder cancer and upper tract urothelial carcinoma, wit…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer [Phase 3]
Phase 3 trial evaluating nivolumab versus placebo after surgery in bladder or upper urinary tract cancer; results completed with posted data…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract [Phase 2]
Phase 2 trial evaluating durvalumab with tremelimumab for metastatic non-transitional cell carcinoma of the urothelial tract shows completed…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention [Phase 1, Phase 2]
Phase 1/2 clinical trial update for an intravesical antifibrinolytic aimed at patients with hematuria and clot retention.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. [Phase 2]
Phase 2 clinical trial update on tisotumab vedotin with continued treatment in patients with various solid tumors, including gynecologic and…